MULTIPLE HATS: STEM Careers | Reinvention | Entrepreneurship |Thought Leadership

MedTech Success Explained with 6 founders - The Triangle of value, The Team, and The Story That Gets Funded

MULTIPLE HATS: STEM Careers | Reinvention | Entrepreneurship |Thought Leadership

Show Notes

What if your MedTech solves a real problem, shows great data… and still never gets used?

🔍 What You’ll Learn: Most STEM professionals focus on building something that works. But in MedTech, success is decided by something far less obvious, whether your product fits into a complex system of people, incentives, and decisions.

In this episode, Angelique pulls together insights from six founders who are all solving very different problems, from oxygen delivery to diagnostics, implants, and digital health. What emerges is a clear pattern of what actually moves a product forward, and what quietly blocks it.

By the end of this episode, you will: • Learn how the triangle of value shapes every MedTech decision, clinical outcome, convenience, and cost • Understand why different stakeholders want different things, and how that creates friction in adoption • Discover what it really takes to build the right team and tell a story that gets funded

This is where you stop thinking like a scientist solving a problem, and start thinking like someone building something that will actually be used.

Press play to see how six founders navigated the reality of MedTech, and what you can apply to your own path.

🧠 About the Guest: In this solo episode, Angelique Greco distils lessons from conversations with six MedTech founders across devices, diagnostics, and digital health. Through their stories, she breaks down the patterns behind products that move forward, and those that stall, showing how success is shaped by the system, not just the science.

📌 Episode Highlights: 00:00 Why great MedTech can fail despite strong science 02:00 The triangle of value explained: outcome, convenience, cost 04:00 ShanShan Wang: one product, three conflicting definitions of value 07:30 Dharmica Mistry: you are not building for the patient 10:00 Anushi Rajapaksa: what changes when you build for the end user 13:00 Ida Tin: creating a new category to be understood 16:00 Ben Wright: when incentives block adoption 21:00 Why the team is the real risk investors look at 24:00 The myth of the scientist-CEO and what actually works 26:00 Venture studios and alternative ways to build a company 30:00 Maryam Parviz: building a team that complements you 34:00 Why storytelling is not optional in MedTech 39:00 Creating a market when none exists 43:00 Final recap: triangle, team, and story

🔗 Resources Mentioned: • Mimetic MedTech Foundry • Roam Technologies • BCAL Diagnostics • Misty • Clue • Xeloda • SDIP Innovations

🎧 Quick fire chat episode: https://shows.acast.com/multiple-hats/episodes/69ad4b747036d73902764808

🤔 Reflection Time: If your work succeeds technically, what could still stop it from being used? Who are the real decision-makers in your space, and what do they optimise for? Are you building something that works, or something that fits?

Want to craft a career story that opens doors? I help STEMM professionals speak with clarity, confidence, and purpose and show up as thought leaders —so the right opportunities find you. 📬 Let’s connect: angeliquegreco.com.au | LinkedIn

⭐️ Help More People Reinvent Their Careers If you enjoyed this episode, please: ✅ Leave a quick ⭐️⭐️⭐️⭐️⭐️ review on Apple Podcasts or Spotify 🙏 ♻️ Share it with a friend who's questioning their path in STEM Hosted on Acast. See acast.com/privacy for more information.

More from MULTIPLE HATS: STEM Careers | Reinvention | Entrepreneurship |Thought Leadership

Oct 12, 2026

You have promising science. But is there actually a commercial opportunity behind it? And if you’re considering moving from scientist to entrepreneur, how do you know whether your research has the ingredients for a biotech company?

Sep 28, 2026

What happens when scientists stop presenting their research to other scientists and put it in front of biotech and drug development experts instead? The questions change. Suddenly it isn’t only, “Does the science work?” It’s also: Who is the patient? What is the indication? What evidence do you need next? What could stop this programme? Who needs to partner with you? And what would a credible path to the clinic actually look like?

Sep 14, 2026

Should your research become a medicine? And if it has commercial potential, should you be the scientist who takes it forward? For academics considering the move from scientist to entrepreneur, that decision starts well before forming a biotech company.

Aug 24, 2026

A rapid-fire conversation on transferable STEM skills, working smarter, visibility and what is actually good enough to start.

Aug 17, 2026

How a nurse turned a recurring healthcare problem into NeedleCalm, and what ten years of building taught her about medtech entrepreneurship.

See all episodes →